MILPITAS, Calif., July 31, 2017 -- IXYS Corporation (NASDAQ:IXYS) today announced that on Wednesday, August 2, 2017 it will report its financial results for its fiscal quarter ended June 30, 2017. The conference call to discuss IXYS’ results will start at 2:00 PM, Pacific Time.
On August 2, 2017, interested parties may join the conference call by dialing the number below five to ten minutes before the conference call is scheduled to begin:
Telephone Number: (323) 794-2130
Conference Code: 5799054
For those unable to join the conference call, there will be a taped replay available beginning at 4:30 PM, Pacific Time on August 2, 2017 that will continue through August 9, 2017. The telephone number for the replay is:
Telephone Number: (719) 457-0820
Conference Code: 5799054
The additional financial information to be discussed in the conference call can be accessed at www.ixys.com on August 2. Click on the Corporate tab in the ixys.com home page. Click on News and Events and then click on IXYS Corporation Financial Information for the period ended June 30, 2017.
Contact: Uzi Sasson CEO and President IXYS Corporation Tel: 408-457-9000


ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



